Related Experiment Video

Updated: May 22, 2026

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches
06:51

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches

Published on: September 5, 2025

Cardiorenal medicine in the changing health system

Kalaivani Mahadevan1, Paul Kalra

  • 1Department of Cardiology, Queen Alexandra Hospital, Portsmouth PO6 3LY, UK.

Journal of Renal Care
|May 11, 2012
PubMed

Insights

Cardiorenal Syndrome, a complex condition affecting heart and kidney health, presents significant global healthcare challenges. Recent research and discussions at the 6th Cardiorenal Forum highlight new insights into its causes and treatments.

Area of Science:

  • Cardiology
  • Nephrology
  • Cardiorenal Medicine

Background:

  • Cardiorenal Syndrome (CRS) is a complex, multifactorial condition involving the heart and kidneys.
  • It poses significant challenges to global healthcare systems.
  • Continuous research is vital for understanding CRS pathophysiology and clinical management.

Framework:

  • The 6th Cardiorenal Forum convened on October 7, 2011, in London.
  • The forum focused on discussing the latest advancements in cardiorenal medicine.
  • Key experts shared new ideas and theories regarding CRS.

Implementation:

  • Discussions covered emerging concepts in the pathophysiology of Cardiorenal Syndrome.
  • Clinical management strategies for CRS were a central topic.
  • The forum facilitated the exchange of cutting-edge research findings.

Implications:

  • Advances discussed at the forum aim to improve patient outcomes for CRS.
  • Enhanced understanding of CRS pathophysiology can lead to novel therapeutic targets.
  • The forum highlighted the collaborative nature of research in cardiorenal medicine.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...